恆指升幅曾擴至逾460點 內險及內房股攀升
港股在期指結算日上升。恆指午後升幅擴大至逾460點,重上萬七關,最新升444點或2.7%,報17,069點,成交額逾770億元。恆生科指升3.9%報3,781。
內地股市升幅擴大,內險股中國平安(02318.HK)、國壽(02628.HK)及中國太平(00966.HK)漲逾5%,眾安在線(06060.HK)升6.1%。內房股顯著上漲,融創中國(01918.HK)升8.7%,碧桂園(02007.HK)及金茂(00817.HK)升6.9%及7.1%、富力(02777.HK)、綠城中國(03900.HK)及雅居樂(03383.HK)升逾6%。
科技股方面,美團(03690.HK)無人機上海楊浦首條航線開航,股價炒高6.5%。京東(09618.HK)亦漲5.3%。阿里巴巴(09988.HK)及騰訊(00700.HK)升2.9%及3.2%。被軟銀減持的商湯(00020.HK)升7.3%。網上醫療平台阿里健康(00241.HK)、平安好醫生(01833.HK)及京東健康(06618.HK)升6%至6.9%。
藍籌內需股李寧(02331.HK)升6.7%。海底撈(06862.HK)及中升(00881.HK)升6%及7.9%。車股理想(02015.HK)及吉利(00175.HK)亦漲近7%。發布新車的小米(01810.HK)則僅升0.9%。
其他藍籌方面,匯控(00005.HK)及友邦(01299.HK)升1%及1.5%,港交所(00388.HK)升3.7%。內銀股招行(03968.HK)升4.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.